US 8008266
Methods of treating cancer using immunostimulatory oligonucleotides
granted A61KA61K2039/55561A61K31/00
Quick answer
US patent 8008266 (Methods of treating cancer using immunostimulatory oligonucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/55561, A61K31/00, A61K31/4706, A61K31/7048